25015903

Liu HY

2015

A subpathway-based method of drug reposition for polycystic ovary syndrome.

25015958

V?rb?r? S

2014

Lower-limb veins are thicker and vascular reactivity is decreased in a rat PCOS model: concomitant vitamin D3 treatment partially prevents these changes.

25017262

Shen SY

2014

Clinical and biochemical characteristics of women with menstrual disturbance.

25019404

Estrada E

2014

Children's Hospital Association consensus statements for comorbidities of childhood obesity.

25020276

Yilmaz SA

2014

Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.

25022555

Kebapcilar AG

2014

Cornea in PCOS patients as a possible target of IGF-1 action and insulin resistance.

25022659

Albu A

2015

Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients.

25022814

Jayasena CN

2014

The management of patients with polycystic ovary syndrome.

25024594

Vassilatou E

2014

Nonalcoholic fatty liver disease and polycystic ovary syndrome.

25024746

Takahashi T

2014

Brachial-to-ankle pulse wave velocity as an independent prognostic factor for ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.

25026923

Turner-McGrievy GM

2014

Low glycemic index vegan or low-calorie weight loss diets for women with polycystic ovary syndrome: a randomized controlled feasibility study.

25029417

Chang CL

2014

Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome.

25029420

Torchen LC

2014

Persistent apparent pancreatic ?-cell defects in premenarchal PCOS relatives.

25035436

Rees E

2014

Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.

25036408

Cengiz H

2014

Comparison of serum anti-M?llerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome.

25039113

Tubi?-Pavlovi? A

2014

Are there any association between polycistic ovary syndrome and congenital abnormalities of M?llerian ducts.

25040369

Cassar S

2014

Polycystic ovary syndrome and anti-M?llerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.

25041270

Livadas S

2015

The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.

25042908

Dinicola S

2014

The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.

25045632

Kim JJ

2014

Vitamin D deficiency in women with polycystic ovary syndrome.

25045633

Chun S

2014

Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-M?llerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome.

25045796

Tian X

2014

Serum anti-M?llerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.

25048421

Yum SK

2014

Polycystic ovaries is a disproportionate signal in pharmacovigilance data mining of second generation antipsychotics.

25049203

Conway G

2014

European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.

25049425

Chuderland D

2014

Role of pigment epithelium-derived factor in the reproductive system.

25050308

Sadrefozalayi S

2014

Effect of the aqueous extract of Foeniculum vulgare (fennel) on the kidney in experimental PCOS female rats.

25051372

Wang XX

2014

Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development.

25052966

Haider S

2014

Influence of anthropometric measurements on abnormal gonadotropin secretion in women with polycystic ovary syndrome.

25053727

Livadas S

2014

Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.

25054962

K?epelka P

2014

[Myo-inositol in the treatment of polycystic ovary syndrome].

25056088

Pinola P

2014

Anti-M?llerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.

25056245

Caserta D

2014

Combined oral contraceptives: health benefits beyond contraception.

25056604

Krysiak R

2014

The effect of ezetimibe on androgen production in hypercholesterolemic women with polycystic ovary syndrome.

25060739

Chang HH

2015

The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.

25061847

Padmanabhan V

2014

Developmental programming: prenatal steroid excess disrupts key members of intraovarian steroidogenic pathway in sheep.

25063700

G?d?ny S

2014

[Importance of the interdisciplinary, evidence-based diagnosis of polycystic ovary syndrome].

25063905

Okyay E

2014

The effect of drospirenone (3 mg) with ethinyl estradiol (30 mcg) containing pills on ovarian blood flows in women with polycystic ovary syndrome: a case controlled study.

25064406

Chen L

2014

Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome.

25065586

Plaza-Parrochia F

2014

The role of androst-5-ene-3?,17?-diol (androstenediol) in cell proliferation in endometrium of women with polycystic ovary syndrome.

25066098

Eid GM

2014

Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass.

25068085

Manner?s-Holm L

2014

Gene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index.

25068307

Sahmay S

2014

Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation.

25069203

Ren LN

2014

[A meta-analysis on acupuncture treatment of polycystic ovary syndrome].

25069671

Jia J

2014

Association between retinol-binding protein 4 and polycystic ovary syndrome: a meta-analysis.

25069836

Pala L

2014

The therapy of insulin resistance in other diseases besides type 2 diabetes.

25070973

Roberts TK

2014

Easy bruising in a patient with secondary amenorrhea.

25070975

Bertholf RL

2014

Commentary.

25078053

Deveci CD

2015

Clomiphene citrate 'stair-step' protocol vs. traditional protocol in patients with polycystic ovary syndrome: a randomized controlled trial.

25078146

Gonz?lez F

2014

The altered mononuclear cell-derived cytokine response to glucose ingestion is not regulated by excess adiposity in polycystic ovary syndrome.

25079455

Pluchino N

2014

Hormonal causes of recurrent pregnancy loss (RPL).

25079709

Hendrix AO

2014

Bifurcation analysis of a menstrual cycle model reveals multiple mechanisms linking testosterone and classical PCOS.

25079765

Krysiak R

2015

The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism.

25083175

Cheraghi E

2014

Co-Administration of Metformin and N-Acetyl Cysteine Fails to Improve Clinical Manifestations in PCOS Individual Undergoing ICSI.

25083576

Thathapudi S

2014

Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study.

25083888

Christakou C

2014

Polycystic ovary syndrome--phenotypes and diagnosis.

25083889

Carmina E

2014

Polycystic ovary syndrome: metabolic consequences and long-term management.

25085801

West S

2014

Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.

25086788

Kim JJ

2014

Gene dose effect between a fat mass and obesity-associated polymorphism and body mass index was observed in Korean women with polycystic ovary syndrome but not in control women.

25088509

Martins WP

2014

Counting ovarian follicles: updated threshold for diagnosis of hyperandrogenic anovulation.

25089371

Almario RU

2015

Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation.

25091221

Yu J

2015

Endometrial preparation protocol of the frozen-thawed embryo transfer in patients with polycystic ovary syndrome.

25092998

Abu Hashim H

2014

Potential role of aromatase inhibitors in the treatment of endometriosis.

25093427

J?drzejuk D

2015

Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome.

25093623

Casarini L

2014

The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation.

25096410

Xu X

2014

Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review.

25096551

Anderson SA

2014

Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysis.

25098041

Irfan A

2013

Effect of metformin hydrochloride in correcting hyperinsulinemia and high leptin levels in treatment of infertile polycystic patients.

25100380

Le?o LM

2014

Nonobese Young Females with Polycystic Ovary Syndrome have Nutritive Microvascular Dysfunction: A Pilot Study.

25100445

Liaqat I

2015

Genetic polymorphisms in Pakistani women with polycystic ovary syndrome.

25100714

Lai H

2014

High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.

25101056

Root-Bernstein R

2014

Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro.

25102689

Fu H

2014

Spleen-yang-deficiency patients with polycystic ovary syndrome have higher levels of visfatin.

25104855

Escobar-Morreale HF

2014

The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency.

25106940

Guruvaiah P

2014

The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women.

25109619

Pohlmeier AM

2014

Effect of a low-starch/low-dairy diet on fat oxidation in overweight and obese women with polycystic ovary syndrome.

25111116

Batista MC

2014

Trp28Arg/Ile35Thr LHB gene variants are associated with elevated testosterone levels in women with polycystic ovary syndrome.

25111328

Bezirganoglu N

2015

Isolated polycystic morphology: Does it affect the IVF treatment outcomes?

25111374

Pereira VM

2014

Downregulation of natriuretic peptide system and increased steroidogenesis in rat polycystic ovary.

25113619

Piomboni P

2014

Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin.

25114670

Enzevaei A

2014

Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?

25117097

Woo HY

2014

Associations of single nucleotide polymorphisms related to insulin resistance with polycystic ovary syndrome.

25118505

Bijok J

2014

[Metformin in pregnancy].

25119192

Wiweko B

2014

Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients.

25119811

Chaabouni K

2014

[Metabolic and inflammatory profiles in polycystic ovary syndrome associated to weight excess].

25123125

H?jlund K

2014

Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.

25124832

Soydan SS

2014

Is the incidence of temporomandibular disorder increased in polycystic ovary syndrome?

25125349

Goss AM

2014

Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS.

25130462

Eriksen MB

2014

Testosterone treatment increases androgen receptor and aromatase gene expression in myotubes from patients with PCOS and controls, but does not induce insulin resistance.

25132618

Fantus IG

2015

Is metformin ready for prime time in pregnancy? Probably not yet.

25136364

Kuliczkowska Plaksej J

2014

Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls.

25137507

Ganie MA

2014

High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).

25138125

Do?anay M

2015

Associations between adipocyte fatty acid-binding protein and clinical parameters in polycystic ovary syndrome.

25138126

Benetti-Pinto CL

2015

The influence of body weight on sexual function and quality of life in women with polycystic ovary syndrome.

25139174

Maruthini D

2014

The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndrome.

25139344

Goldberg-Stern H

2014

Endocrine effects of valproic acid therapy in girls with epilepsy: a prospective study.

25141961

Tal R

2014

Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation.

25144631

Roemer KL

2014

Characterization of GAB1 expression over the menstrual cycle in women with and without polycystic ovarian syndrome provides a new insight into its pathophysiology.

25145761

Gencer M

2014

The relationship between subclinical cardiovascular disease and lipocalin-2 levels in women with PCOS.

25148265

Scholten M

2015

Atypical polycystic ovary syndrome--a genetic analysis.

25150387

Zhang D

2014

Genome-wide identification of?aberrantly methylated promoters in?ovarian tissue of prenatally androgenized rats.